After MediWound announced that CEO Gal Cohen has decided to step down, SunTrust analyst Bruce Nudell said he believes the fact that Cohen is pursuing another opportunity while retaining his share interest in MediWound, along with the lack of formal search for a successor, is “consistent with the notion that a strategic deal is near in hand.” Nudell has a Buy rating and $9 price target on MediWound shares.
https://thefly.com/landingPageNews.php?id=2877931
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.